Drug Type Small molecule drug |
Synonyms NK 109, NK-109 |
Action inhibitors |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H16ClNO4 |
InChIKeyCUXBKFBSLWHZGW-UHFFFAOYSA-N |
CAS Registry149998-49-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | Japan | - | |
Thrombosis | Preclinical | Japan | - |